Aerobic training in patients with anoctamin 5 myopathy and hyperckemia

Christoffer R Vissing, Nicolai Preisler, Edith Husu, Kira P Prahm, John Vissing

22 Citations (Scopus)

Abstract

INTRODUCTION: Anoctamin 5 deficiency has recently been defined to cause limb-girdle muscular dystrophy type 2L (LGMD2L) with pronounced hyperCKemia. No treatment interventions have been made so far in this condition.

METHODS: In 6 patients with LGMD2L, we studied the effect of home-based, pulse-watch monitored, moderate-intensity exercise on a cycle ergometer for 30 minutes, 3 times weekly, for 10 weeks. Plasma creatine kinase (CK) was assessed before, during, and after the program as a marker of muscle damage. Primary outcome measures were maximum oxygen uptake (VO(2max)) and time in the 5-repetitions-sit-to-stand test (FRSTST).

RESULTS: Training resulted in improvements in VO(2max) (27 ± 7%; P = 0.0001) and FRSTST time (35 ± 12%; P = 0.007). Improvements in physiologic and functional muscle testing were accompanied by stable CK levels and no reports of adverse effects.

CONCLUSIONS: These findings suggest that supervised aerobic exercise training is safe and effective in improving oxidative capacity and muscle function in patients with anoctamin 5 deficiency.

Original languageEnglish
JournalMuscle & Nerve
Volume50
Issue number1
Pages (from-to)119-23
Number of pages5
ISSN0148-639X
DOIs
Publication statusPublished - Jul 2014

Keywords

  • Adult
  • Anaerobic Threshold
  • Chloride Channels
  • Creatine Kinase
  • Exercise
  • Exercise Test
  • Female
  • Heart Rate
  • Humans
  • Male
  • Middle Aged
  • Mobility Limitation
  • Muscular Dystrophies, Limb-Girdle
  • Mutation
  • Neurologic Examination
  • Patient Compliance
  • Physical Education and Training
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Aerobic training in patients with anoctamin 5 myopathy and hyperckemia'. Together they form a unique fingerprint.

Cite this